01Dec
Americas Antitrust Review 2021
Covid-19 has made 2020 into a year like no other with ‘stay at home’ orders and working from home the new normal. Nonetheless, the tech and pharma industries continued to attract immense antitrust scrutiny, with daily reports in the media and pressure from politicians to address what some perceive to be anticompetitive mergers by digital platforms and pharmaceutical companies, even while innovation in both sectors continues at breakneck speed. In this article, we discuss some of the most...
By:
Cooley LLP
Related
As you may know, the Department of Labor has included the proposal of a new fiduciary rule on its Re...
Read More >
On September 3, 2020, the U.S. Department of Justice’s (DOJ) Antitrust Division released a revised ...
Read More >
Workplace Changes for Workers in the Screen Industry Proposed Bill or Initiative - Key changes in N...
Read More >
On June 10, 2019, the Supreme Court of the United States unanimously ruled that state wage and hour ...
Read More >
When an employee requests an accommodation or asserts a claim under the Americans with Disabilities ...
Read More >
Seyfarth Synopsis: In Flaherty v. Entergy Nuclear Operations, Inc., ___ F.3d ___, No. 18-1759, 2019 ...
Read More >